Replies to post #482914 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

….And from a patient and market perspective, that 20% in the real world, that cannot tolerate initial chemo radiation, could, instead of being removed from a trial, placed immediately on DCVax-l.

That alone is 20% of the market and, more importantly, 20% of patients that have no where else to turn too, given real hope.